Skip to content
Longevity Peptide

Epithalon (Epitalon)

A synthetic tetrapeptide (Ala-Glu-Asp-Gly) modelled on the pineal gland extract Epithalamin. The long-term human mortality data are for Epithalamin and come from one research network; the telomere-elongation finding for Epithalon comes from human cell culture, not from people.

longevitysleepanti-aging
Tier B— Generally safe — moderate evidence
Evidence gradeC — Animal studies / Case reports
BH

Editorially reviewed by

BiohackingHub Research Team

Editorial Team · Last updated: November 18, 2026

Mechanism of Action

Epithalon (also spelled Epitalon) is a synthetic tetrapeptide -- Ala-Glu-Asp-Gly -- developed at the St. Petersburg Institute of Bioregulation and Gerontology.

Key mechanisms:

  • Telomerase activation -- in human cell culture, Epithalon induced telomerase, the enzyme responsible for maintaining telomere length. Telomere shortening is one of the primary hallmarks of cellular ageing
  • Pineal gland regulation -- stimulates melatonin secretion, normalising circadian rhythm disruptions common with advancing age
  • Antioxidant effect -- reduces lipid peroxidation and oxidative stress in multiple tissue types
  • Neuroendocrine restoration -- modulates the hypothalamic-pituitary axis, supporting hormonal homeostasis

Human Evidence

The human data are for Epithalamin, the pineal extract, and come from one research network. In a cohort of 266 older adults followed for 6-8 years, mortality was reported 1.6-1.8 times lower with Epithalamin than in controls. In a separate 12-year randomized study of older patients with coronary disease, 28% fewer people died in the Epithalamin group, and cardiovascular mortality was two times lower. No independent group has repeated either study.

For Epithalon itself, the key finding is from cell culture: added to human fetal fibroblasts, it induced telomerase activity and telomere elongation. Telomere length has not been measured in people taking it.

Dosing Protocol

Standard cycle: 10mg/day subcutaneous for 10-20 consecutive days, repeated 2-3 times per year.

Community convention: 5-10mg/day for 10 days, twice per year (spring and autumn). The published abstracts of the human studies do not state a dose.

Why This Belongs in the Longevity Section

The telomere finding is what draws attention to Epithalon, but it comes from cell culture; the human mortality data are for Epithalamin and from a single research network. The graded course, with monitoring and stop rules, is in The Bio-Clock Reset Protocol.

Related Research

Stacking Interactions

How Epithalon (Epitalon) interacts with other compounds

+
NMNSynergisticweak evidence

NMN restores NAD+ for DNA repair; Epithalon activates telomerase for telomere maintenance. Complementary longevity mechanisms — Epithalon during cycles, NMN daily.

=
ResveratrolNeutralanecdotal evidence

Both target longevity pathways independently. No known interaction. Safe to co-administer.

Protocols using Epithalon (Epitalon)

Evidence-graded stacks that include this compound

Safety Profile — Tier B

Generally safe — moderate evidence

Contraindications

  • ●Active cancer (promotes cell proliferation via telomerase activation)
  • ●Autoimmune diseases — use with caution

Side Effects

  • ●Generally well-tolerated in clinical studies
  • ●Mild local reaction at injection site
  • ●Vivid dreams reported by some users

Drug Interactions

No established drug interactions — research is limited